Historical record - last NADAC effective date: 11/22/2023
Product Information
CELECOXIB 400 MG CAPSULE is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.3454 per EA under NDC 75834023960. Its NADAC has been published 142 times since Dec 23, 2020.
FDA first approved this application on Nov 27, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834023960
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
11/22/2023
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA210628FDA Approved
11/27/2019
TE Code
AB
On Market Since
9/3/2020
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 400 MG CAPSULE has been published 142 times since Dec 23, 2020, and over the history we have for it it has declined 46.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3454 per EA |
|---|---|
| All-time high | $0.9292 (Apr 14, 2021) |
| All-time low | $0.2939 (Apr 19, 2023) |
| Median price | $0.4741 |
| Average price | $0.5448 |
| Largest weekly change | +54.7% (Jun 22, 2022) |
| Weeks tracked | 142 |
| Tracking since | Dec 23, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.9%
5Y
-50.8%
All
-46.0%
Last surveyed Nov 29, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CELECOXIB 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 400 MG CAPSULE, manufactured by Nivagen Pharmaceuticals Inc., is $0.3454 per EA (NDC 75834023960), effective Nov 29, 2023.
How has the price of CELECOXIB 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 400 MG CAPSULE has declined 46.0%. It has been tracked across 142 weekly CMS publications since Dec 23, 2020.
What are the highest and lowest recorded NADAC prices for CELECOXIB 400 MG CAPSULE?
Since Dec 23, 2020, the NADAC for CELECOXIB 400 MG CAPSULE has ranged from a low of $0.2939 (Apr 19, 2023) to a high of $0.9292 (Apr 14, 2021), with a median of $0.4741 per EA.
Are there cheaper alternatives to CELECOXIB 400 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 400 MG CAPSULE, is $0.2228 per EA — about 36% below CELECOXIB 400 MG CAPSULE.
Who manufactures CELECOXIB 400 MG CAPSULE?
CELECOXIB 400 MG CAPSULE (NDC 75834023960) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.